Form D · Pharmaceuticals
GNT Pharmaceuticals, Inc.
Louisville, KY · CIK 0002057459
Offering snapshot reported Mar 3, 2025 · SEC filing
- Reported sold
- Yet to sell Offering amount: $150K
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 3, 2025 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-539593
Source: Form D, filed Mar 3, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Dale Boden | Director |
| Jim Corman | Director |
| Larry Horn | Director, Executive |
| Serge Martinod | Director |
| Phoebe Wood | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
3711 Quail Hollow Court
Louisville, KY, 40241
Phone: 502-894-0295
Louisville, KY, 40241
Phone: 502-894-0295